Mäkipernaa A - Search Results

1

[Menorrhagia in adolescents: normal or a sign of underlying medical condition?].

Vuori-Holopainen E, Mäkipernaa A, Tiitinen A. Vuori-Holopainen E, et al. Among authors: makipernaa a. Duodecim. 2013;129(24):2613-20. Duodecim. 2013. PMID: 24471204 Review. Finnish.

2

[Woman and von Willebrand disease].

Hurskainen R, Halmesmäki E, Rasi V, Mäkipernaa A. Hurskainen R, et al. Among authors: makipernaa a. Duodecim. 2003;119(1):33-40; quiz 40, 78. Duodecim. 2003. PMID: 12607470 Review. Finnish. No abstract available.

3

[Transient hemorrhagic diathesis caused by prothrombin-binding antiphospholipid antibody in a child].

Möttönen M, Hiltunen L, Rajantie J, Juntti H, Mäkipernaa A. Möttönen M, et al. Among authors: makipernaa a. Duodecim. 2014;130(20):2108-11. Duodecim. 2014. PMID: 25558609 Finnish.

4

[Strongyloides stercoralis parasite causing generalized infection].

Ashorn P, Lumio J, Vuento R, Mäkipernaa A. Ashorn P, et al. Among authors: makipernaa a. Duodecim. 1993;109(21):1940-4. Duodecim. 1993. PMID: 7743950 Finnish. No abstract available.

5

[Why does a man have bruises after sawing wood in order to warm up the sauna?].

Kauppila M, Mäkipernaa A. Kauppila M, et al. Among authors: makipernaa a. Duodecim. 2003;119(17):1669-71. Duodecim. 2003. PMID: 14587447 Finnish. No abstract available.

6

Rapid intravenous immunoglobulin infusions in children with idiopathic thrombocytopenic purpura.

Rajantie J, Mäkipernaa A, Lanning M. Rajantie J, et al. Among authors: makipernaa a. Eur J Pediatr. 1994 Nov;153(11):862. doi: 10.1007/BF01972900. Eur J Pediatr. 1994. PMID: 7843205 No abstract available.

7

Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.

Kanerva J, Saarinen-Pihkala UM, Niini T, Riikonen P, Möttönen M, Mäkipernaa A, Salmi TT, Vettenranta K, Knuutila S. Kanerva J, et al. Among authors: makipernaa a. Pediatr Blood Cancer. 2004 Jan;42(1):30-5. doi: 10.1002/pbc.10417. Pediatr Blood Cancer. 2004. PMID: 14752791

8

Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL.

Kanerva J, Tiirikainen M, Mäkipernaa A, Riikonen P, Möttönen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Kanerva J, et al. Among authors: makipernaa a. Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):11-21. doi: 10.3109/08880019809009504. Pediatr Hematol Oncol. 1998. PMID: 9509502

9

Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.

Vepsäläinen K, Lassila R, Arola M, Lähteenmäki P, Möttönen M, Mäkipernaa A, Riikonen P. Vepsäläinen K, et al. Among authors: makipernaa a. Haemophilia. 2015 Nov;21(6):747-53. doi: 10.1111/hae.12665. Epub 2015 Mar 31. Haemophilia. 2015. PMID: 25832453

10

Improved prognosis for children with stage IV neuroblastoma: high-dose melphalan and autologous unpurged marrow transplantation after aggressive surgery and short chemotherapy with cisplatinum and etoposide.

Rajantie J, Wikström S, Perkkiö M, Hovi L, Mäkipernaa A, Maunuksela EL, Siimes MA. Rajantie J, et al. Among authors: makipernaa a. Pediatr Hematol Oncol. 1988;5(2):125-35. doi: 10.3109/08880018809031262. Pediatr Hematol Oncol. 1988. PMID: 3152958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters